Active Ingredient History

NOW
  • Now
Edaravone is a free radical scavenger developed for the treatment of amyotrophic lateral sclerosis.   NCATS

  • SMILES: CC1=NN(C(O)=C1)C2=CC=CC=C2
  • InChIKey: PLVBQEFRONZLHO-UHFFFAOYSA-N
  • Mol. Mass: 174.1992
  • ALogP: 1.8
  • ChEMBL Molecule:
More Chemistry
  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Parenteral
  • Pro Drug: No

Drug Pricing (per unit)

United States

$426.1350 - $542.4900
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

1-phenyl-3-methyl-5-oxo-2-pyrazoline | 1-phenyl-3-methyl-5-pyrazolone | 2,4-dihydro-5-methyl-2-phenyl-3h-pyrazol-3-one | 3h-pyrazol-3-one, 2,4-dihydro-5-methyl-2-phenyl- | 3-methyl-1-phenyl-2-pyrazolin-5-one | 3-methyl-1-phenyl-5-pyrazolone | 3-methyl-1-phenylpyrazol-5-one | c.i. developer 1 | developer z | edarabone | edaravone | mci 186 | mci-186 | methylphenylpyrazolone | norantipyrine | norphenazone | phenylmethylpyrazolone | phenyl methyl pyrazolone | radicava | radicut

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue